Home
Contact Us
About Us
Advertise
Biotech
Finance
Tech News
Disclaimer
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
BioPharmaJournal
Home
Contact Us
About Us
Advertise
Biotech
Stability and Dividend Potential of Healthcare Stocks (GILD,BMY,DHR)
Reason why Enzo Biochem (NYSE:ENZ) surged on Friday
Corbus Pharmaceuticals Holdings Inc (NASDAQ:CRBP) surges ahead of AACR Presentation
Vallon Pharmaceuticals Inc (VLON) stock could be just getting started
Creative Medical Technology Holdings Inc (CELZ) could double from current levels
Finance
Silvergate Capital Corp (NYSE:SI) Dramatic Surge: Exploring Potential Causes and Future…
Is the rally in Intelligent Bio Solutions Inc (INBS) stock sustainable…
Applied DNA Sciences Inc (APDN) could keep surging and here’s why
Aeglea Bio Therapeutics Inc (NASDAQ: AGLE) Announces EMA Marketing Authorization Validation…
Why Your Body Needs Nitric Oxide Boost Beets For More Energy…
Tech News
Aehr Test Systems (NASDAQ: AEHR) Receives an Order of $10.8 Million…
Tauriga Sciences Inc (OTCMKTS:TAUG) Could React on New Aegea Rapid Test…
Micro and Macro Tailwinds Converge for KULR
ISWH and the Rebirth of the Crypto Cycle
Disclaimer
Home
Tags
NASDAQ:SAVA
Tag: NASDAQ:SAVA
Cassava Sciences Inc. (NASDAQ: SAVA) Launches New Clinical Website Offering Information...
Gavins Felicity
-
January 3, 2022
0
Journal of Neuroscience Didn’t Find Data Manipulation Evidence in Research Article...
Matt Wade
-
November 17, 2021
0
Annovis Bio Inc (NYSEAMERICAN: ANVS), Cassava Sciences Inc (NASDAQ: SAVA), Honest...
Kate Hudson
-
October 11, 2021
0
Cassava Sciences Inc. (NASDAQ: SAVA) Releases Clinical Data On Simufilam In...
Matt Wade
-
September 28, 2021
0
Cassava Sciences Inc. (NASDAQ:SAVA) Released Addition Phase 2b Clinical Study Results...
Ward Sport
-
November 10, 2020
0
CTAD 2020 Picks Cassava Sciences Inc.’s (NASDAQ:SAVA) Phase 2b Sumifilam Study...
Matt Wade
-
October 14, 2020
0
Cassava Sciences Inc. (NASDAQ:SAVA) Demonstrates Directional Improvement In Alzheimer’s Patients Treated...
Matt Wade
-
September 17, 2020
0
The USAN Announces a Commercial Brand Name for PTI-125; Lead Drug...
Kate Hudson
-
September 1, 2020
0
Cassava Sciences Inc (NASDAQ:SAVA) Expects To Release Clinical Results Of Phase...
Kate Hudson
-
August 26, 2020
0
Recent Post
Stocks In focus ahead as Wall Street grows hopeful of a...
Kate Hudson
-
May 26, 2023
0
The Invesco QQQ’s made new 12-month highs this morning and continue to climb. The QQQ’s are testing prior resistance of $347. It...
Super Micro Computer’s Q4 Outlook ($SMCI) Boosts Investor Confidence Despite Q3...
May 3, 2023
IPOs are starting to heat up again (TRNR,GNLX,TCJH)
May 1, 2023
TOP Financial Group Limited ($TOP) surges over 600% after market hours
April 27, 2023
Penny Stocks are back in focus (BBD,DIDIY,APE,TLRY,FCEL)
April 27, 2023
